In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Managing Pharma's Competing Challenges In The New Health Economy

Executive Summary

The shifts roiling the health care industry are creating an entirely new commercial landscape. PwC says that the way pharma companies opt to address three pivotal challenges – patient engagement, analytics and value – will affect not only their future, but the future direction of patient care, provider decisions and payment mechanisms.

You may also be interested in...



Pharma In The New Health Economy: Pressures From Accelerating Market Trends

Health care reforms aimed at reducing medical costs will affect pharmaceutical companies more rapidly and in different ways than expected, thanks to accelerated changes by payors and providers. The three big trends that will reshape the health care market, and what pharmas need to do to counterbalance their effect.

Aligning Expectations: Can the US FDA and Industry Meet in the Middle?

Aligning Expectations: Can the US FDA and Industry Meet in the Middle?

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV005061

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel